In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies.

Although the PFF-injected group collectively displayed a trend towards attenuated weight gain compared to PBS-injected animals, this trend did not reach statistical significance (Fig. 3 E).

also in 111,027 other papers